OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19
Miklós Bege, Anikó Borbás
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 14
Miklós Bege, Anikó Borbás
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 14
Showing 14 citing articles:
A patent review of CYP3A4 inhibitors (2018 - present)
Dong‐Zhu Tu, Xueyan Hu, J. Lei, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Dong‐Zhu Tu, Xueyan Hu, J. Lei, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Insight into the Role of the Aryl Hydrocarbon Receptor in Bovine Coronavirus Infection by an Integrated Approach Combining In Vitro and In Silico Methods
Luca Del Sorbo, Clementina Acconcia, Maria Michela Salvatore, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 579-579
Open Access
Luca Del Sorbo, Clementina Acconcia, Maria Michela Salvatore, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 579-579
Open Access
Advancing Viral Defense: Unravelling the Potential of Host-Directed Antivirals Against SARS-CoV-2
Zheng Yao Low, Siau Wui Chin, Sharifah Syed Hassan, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 2, pp. 13-13
Open Access
Zheng Yao Low, Siau Wui Chin, Sharifah Syed Hassan, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 2, pp. 13-13
Open Access
Latest advances in research methods for high-yield cellulase production
Xinxin Xiang, Youhong Zhang, Wei Wei, et al.
Sustainable Energy & Fuels (2025)
Closed Access
Xinxin Xiang, Youhong Zhang, Wei Wei, et al.
Sustainable Energy & Fuels (2025)
Closed Access
A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (Mpro) of SARS-CoV-2 and MERS-CoV
Pu Chen, Tayla J. Van Oers, Elena Arutyunova, et al.
JACS Au (2024) Vol. 4, Iss. 8, pp. 3217-3227
Open Access | Times Cited: 3
Pu Chen, Tayla J. Van Oers, Elena Arutyunova, et al.
JACS Au (2024) Vol. 4, Iss. 8, pp. 3217-3227
Open Access | Times Cited: 3
Nirmatrelvir: From Discovery to Modern and Alternative Synthetic Approaches
Michela Galli, Francesco Migliano, Valerio Fasano, et al.
Processes (2024) Vol. 12, Iss. 6, pp. 1242-1242
Open Access | Times Cited: 2
Michela Galli, Francesco Migliano, Valerio Fasano, et al.
Processes (2024) Vol. 12, Iss. 6, pp. 1242-1242
Open Access | Times Cited: 2
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Assay Development and Validation for Innovative Antiviral Development Targeting the N-Terminal Autoprocessing of SARS-CoV-2 Main Protease Precursors
Liangqun Huang, Megan Gish, James Boehlke, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1218-1218
Open Access | Times Cited: 1
Liangqun Huang, Megan Gish, James Boehlke, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1218-1218
Open Access | Times Cited: 1
Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors
Yuka Otsuka, Lizhou Zhang, Huihui Mou, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 6, pp. 100178-100178
Open Access | Times Cited: 1
Yuka Otsuka, Lizhou Zhang, Huihui Mou, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 6, pp. 100178-100178
Open Access | Times Cited: 1
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management
Christos Papaneophytou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8105-8105
Open Access
Christos Papaneophytou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8105-8105
Open Access
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening
Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 6, pp. 100181-100181
Open Access
Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 6, pp. 100181-100181
Open Access
The problem of SARS-CoV-2 virus resistance to direct-acting antivirals
Е. Л. Гасич, Е. Н. Кроткова, A. D. Kasko, et al.
Biological Products Prevention Diagnosis Treatment (2024)
Open Access
Е. Л. Гасич, Е. Н. Кроткова, A. D. Kasko, et al.
Biological Products Prevention Diagnosis Treatment (2024)
Open Access
Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies
Reham F. Barghash, Donato Gemmati, Ahmed M. Awad, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5564-5564
Open Access
Reham F. Barghash, Donato Gemmati, Ahmed M. Awad, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5564-5564
Open Access
Evolving Impact of COVID‐19 on Intestinal Transplant Recipients: A Single‐Center Experience
Colin Powers, Brielle Corrente, Jennifer Joyce, et al.
Clinical Transplantation (2024) Vol. 39, Iss. 1
Open Access
Colin Powers, Brielle Corrente, Jennifer Joyce, et al.
Clinical Transplantation (2024) Vol. 39, Iss. 1
Open Access
